The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions

K Dheda, T Perumal, H Moultrie, R Perumal… - The Lancet …, 2022 - thelancet.com
The global tuberculosis burden remains substantial, with more than 10 million people newly
ill per year. Nevertheless, tuberculosis incidence has slowly declined over the past decade …

Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection

PK Drain, KL Bajema, D Dowdy, K Dheda… - Clinical microbiology …, 2018 - Am Soc Microbiol
Tuberculosis (TB) is the leading infectious cause of mortality worldwide, due in part to a
limited understanding of its clinical pathogenic spectrum of infection and disease …

[图书][B] WHO consolidated guidelines on tuberculosis. Module 2: screening-systematic screening for tuberculosis disease

World Health Organization - 2021 - books.google.com
The WHO consolidated guidelines on tuberculosis. Module 2: screening–systematic
screening for tuberculosis disease is an updated and consolidated summary of WHO …

[HTML][HTML] Global epidemiology of tuberculosis and progress toward meeting global targets—worldwide, 2018

A MacNeil - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Global Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets —
Worldwide, 2018 | MMWR Skip directly to site content Skip directly to page options Skip directly …

Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection

LCK Bell, M Noursadeghi - Nature Reviews Microbiology, 2018 - nature.com
Co-infection with Mycobacterium tuberculosis is the leading cause of death in individuals
infected with HIV-1. It has long been known that HIV-1 infection alters the course of M …

[HTML][HTML] Global epidemiology of tuberculosis and progress toward achieving global targets—2017

A MacNeil - MMWR. Morbidity and mortality weekly report, 2019 - cdc.gov
Global Epidemiology of Tuberculosis and Progress Toward Achieving Global Targets — 2017 |
MMWR Skip directly to site content Skip directly to page options Skip directly to AZ link Centers …

Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance

M Kohli, I Schiller, N Dendukuri… - Cochrane Database …, 2018 - cochranelibrary.com
Background Tuberculosis (TB) is the world's leading infectious cause of death.
Extrapulmonary TB accounts for 15% of TB cases, but the proportion is increasing, and over …

Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis

HE Jenkins, CM Yuen, CA Rodriguez… - The Lancet Infectious …, 2017 - thelancet.com
Background Case fatality ratios in children with tuberculosis are poorly understood—
particularly those among children with HIV and children not receiving tuberculosis treatment …

CheXaid: deep learning assistance for physician diagnosis of tuberculosis using chest x-rays in patients with HIV

P Rajpurkar, C O'Connell, A Schechter, N Asnani… - NPJ digital …, 2020 - nature.com
Tuberculosis (TB) is the leading cause of preventable death in HIV-positive patients, and yet
often remains undiagnosed and untreated. Chest x-ray is often used to assist in diagnosis …

Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind …

A Gupta-Wright, EL Corbett, JJ van Oosterhout… - The Lancet, 2018 - thelancet.com
Background Current diagnostics for HIV-associated tuberculosis are suboptimal, with
missed diagnoses contributing to high hospital mortality and approximately 374 000 annual …